W. Luttmann (Rostock, Germany), A. Frew (Southampton, United Kingdom)
Metalloproteinase 1 expression in distal lung of fatal asthma L. F. Silva, B. B. Araujo, S. Fernezlian, P. H. Saldiva, M. Dolhnikoff, T. Mauad (Sao Paulo, Brazil)
| |
Collagen type III content in large airways and distal lung of fatal asthma B. B. Araújo, L. F. Silva, H. A. Gomes, S. Fernezlian, P. H. Saldiva, M. Dolhnikoff, T. Mauad (Sao Paulo, Brazil)
| |
Serum TNFα and IL8 as markers of systemic inflammation in severe asthma M. Silvestri, M. Bontempelli, M. Giacomelli, G. A. Rossi, A. Rossi, F. L. Ricciardolo (Genoa, Bergamo, Italy)
| |
Serum levels of IL-8, IL-10 and TNFα in severe allergic asthma G. Lombardo, O. Bertuccio, G. R. Lombardo, A. Carnì, P. Quattrocchi (Messina, Italy)
| |
Enhanced severity of virus associated asthma exacerbations is not associated with delayed viral clearance and increased viral load A. P. E. Sachs, L. J. R. van Elden, T. A. M. van Loon, T. T. G. Kimman, T. J. M. Verheij, M. M. D. Nijhuis (Utrecht, Bilthoven, Netherlands)
| |
Serologic immunoglobulin E responses against Aspergillus and Candida in patients with chronic asthma E. M. Rekalova, I. F. Ilyinskaya, S. G. Yasyr (Kiev, Ukraine)
| |
Exhaled nitric oxide (FENO) in patients with rhinitis and asthma-like symptoms E. Heffler, G. Guida, R. Bergia, F. Nebiolo, P. Marsico, G. Rolla (Turin, Italy)
| |
Inflammation and diagnosis of asthma: exhaled nitric oxide (FENO) and induced sputum eosinophil count A. Fortuna, N. Calaf, M. Gonzalez, T. Feixas, E. Codina, M. Torrejon, R. Aparicio, J. Belda, P. Casan (Barcelona, Spain)
| |
The expression of platelet-derived CD40L and its clinical significance in asthma J. A. Huang, W. Lei, X. G. Zhang (Suzhou, China)
| |
Exhaled NO and bronchial asthma H. H. Razzouk, F. F. Faraj, M. M. Razzouk, O. O. Massot (Briançon, Villard Saint Pancrace, France)
| |
Exhaled nitric oxide (eNO) for an epidemiological study in adults J. Saito, H. Hasunuma, Y. Ishimaru, H. Kanegae, S. Kudo, M. Munakata (Fukushima, Tokyo, Japan)
| |
The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma A. V. Lisitsa, S. K. Soodaeva, I. A. Klimanov (Moscow, Russian Federation)
| |
Exhaled nitric oxide for diagnosing asthma in Chinese and Malays A. K. Tee, R. Ihsan, S. Lim, K. Hui (Singapore, Singapore)
| |
Allergen sensitization in patients with cough variant asthma (CVA) G. D. Meletis, E. N. Thanou, M. L. Ferdoutsis, F. N. Oikonomidou, K. Thimaki, A. M. Kaltsounaki, G. M. Patsourakis, V. Liakou, N. Bachlitzanakis (Heraklion, Greece)
| |
Investigation of nitric oxide level in the exhaled breath condensate in asthma and COPD patients V. V. Bojarko, L. I. Volkova (Tomsk, Russian Federation)
| |
Steroid-induced BAL lymphocyte (L-BAL) apoptosis as prognostic factor in patients with bronchial asthma (AB) P. Kopinski, J. Soja, G. Pinis, A. Dyczek, H. Rybarczyk, K. Sladek, J. Szczeklik (Krakow, Bydgoszcz, Poland)
| |
Plasma TGF β1 levels in stable asthmatics and correlation between disease severity E. Ozyilmaz, S. Canbakan, N. Capan, A. Erturk, M. Gulhan, M. Oktem (Ankara, Turkey)
| |
The pathological feature of airway inflammation in eosinophilic bronchitis W. Luo, K. Lai, R. Chen (GuangZhou, China)
| |
Study on relationship between the haplotypes of polymorphisms in β2-AR and asthma Q. Gong, L. M. Dai, L. Y. Zhang, M. Yang, J. Q. Zhang (Kunming, China)
| |